JO2726B1 - Derivatives 4- (3-benzoylaminophenyl) -6,7-dimethoxy-2-methylaminokinazoline - Google Patents

Derivatives 4- (3-benzoylaminophenyl) -6,7-dimethoxy-2-methylaminokinazoline

Info

Publication number
JO2726B1
JO2726B1 JO200752A JOP20070052A JO2726B1 JO 2726 B1 JO2726 B1 JO 2726B1 JO 200752 A JO200752 A JO 200752A JO P20070052 A JOP20070052 A JO P20070052A JO 2726 B1 JO2726 B1 JO 2726B1
Authority
JO
Jordan
Prior art keywords
methylaminoquinazolin
benzoylaminophenyl
dimethoxy
derivatives
optionally substituted
Prior art date
Application number
JO200752A
Other languages
Arabic (ar)
English (en)
Inventor
مايزاكي كازوكي
تاكاسي يوسوتاكا
اسانو اوسامو
شيراتو مانابو
واكيتا هيساشي
سايكي تاكاو
ايشي ناوتو
كوسانو كازوتومي
Original Assignee
ايساي ار و دي مانجمنت كو., ليمتد.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ايساي ار و دي مانجمنت كو., ليمتد. filed Critical ايساي ار و دي مانجمنت كو., ليمتد.
Application granted granted Critical
Publication of JO2726B1 publication Critical patent/JO2726B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JO200752A 2006-02-21 2007-02-20 Derivatives 4- (3-benzoylaminophenyl) -6,7-dimethoxy-2-methylaminokinazoline JO2726B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006043273 2006-02-21

Publications (1)

Publication Number Publication Date
JO2726B1 true JO2726B1 (en) 2013-09-15

Family

ID=42137992

Family Applications (1)

Application Number Title Priority Date Filing Date
JO200752A JO2726B1 (en) 2006-02-21 2007-02-20 Derivatives 4- (3-benzoylaminophenyl) -6,7-dimethoxy-2-methylaminokinazoline

Country Status (17)

Country Link
JP (1) JP4778550B2 (de)
KR (1) KR101278852B1 (de)
AT (1) ATE517875T1 (de)
BR (1) BRPI0708098B8 (de)
CY (1) CY1112554T1 (de)
DK (1) DK1992622T3 (de)
ES (1) ES2368089T3 (de)
HR (1) HRP20110604T1 (de)
IL (1) IL193322A (de)
JO (1) JO2726B1 (de)
MY (1) MY146275A (de)
NZ (1) NZ569936A (de)
PT (1) PT1992622E (de)
RS (1) RS51969B (de)
RU (1) RU2431632C2 (de)
SI (1) SI1992622T1 (de)
TW (1) TWI404709B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8530654B2 (en) 2007-02-16 2013-09-10 Eisai R&D Management Co., Ltd. Crystals, amorphous substances or salts of methyl N-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl) phenyl] terephthalamic acid
AU2008290000B2 (en) 2007-08-17 2012-05-10 Eisai R & D Management Co., Ltd. Method for producing quinazoline derivative
CA2696793A1 (en) 2007-08-17 2009-02-26 Eisai R&D Management Co., Ltd. Novel preparation for external use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9300059D0 (en) * 1992-01-20 1993-03-03 Zeneca Ltd Quinazoline derivatives
US6262069B1 (en) * 1997-08-29 2001-07-17 Protherics Molecular Design Limited 1-amino-7-isoquinoline derivatives as serine protease inhibitors
AR015966A1 (es) * 1997-10-17 2001-05-30 Smithkline Beecham Corp Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito
JPH11209350A (ja) 1998-01-26 1999-08-03 Eisai Co Ltd 含窒素複素環誘導体およびその医薬
US7687502B2 (en) * 2004-03-23 2010-03-30 Banyu Pharmaceutical Co., Ltd. Substituted quinazoline or pyridopyrimidine derivative

Also Published As

Publication number Publication date
SI1992622T1 (sl) 2011-11-30
DK1992622T3 (da) 2011-09-05
JPWO2007097317A1 (ja) 2009-07-16
TWI404709B (zh) 2013-08-11
RS51969B (sr) 2012-02-29
KR20080094811A (ko) 2008-10-24
BRPI0708098A2 (pt) 2011-05-17
TW200812980A (en) 2008-03-16
MY146275A (en) 2012-07-31
PT1992622E (pt) 2011-09-19
KR101278852B1 (ko) 2013-07-01
ES2368089T3 (es) 2011-11-14
ATE517875T1 (de) 2011-08-15
CY1112554T1 (el) 2016-02-10
IL193322A0 (en) 2009-05-04
JP4778550B2 (ja) 2011-09-21
RU2008137654A (ru) 2010-03-27
HRP20110604T1 (hr) 2011-09-30
IL193322A (en) 2014-04-30
HK1122025A1 (en) 2009-05-08
NZ569936A (en) 2010-07-30
BRPI0708098B1 (pt) 2019-08-06
RU2431632C2 (ru) 2011-10-20
BRPI0708098B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
MY148703A (en) Polycyclic cinnamide derivatives
MY150507A (en) Polycyclic compound
MY150989A (en) Benzothiazole compounds useful for raf inhibition
WO2009028629A1 (ja) 複素環化合物およびその用途
WO2007125547A3 (en) Novel process for statins and its pharmaceutically acceptable salts thereof
PH12013501873A1 (en) Novel imidazo-oxazine compound or salt thereof
WO2005074603A3 (en) Aminobenzoxazoles as therapeutic agents
WO2009048101A1 (ja) アミド化合物
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
WO2008019395A3 (en) Compounds for improving learning and memory
WO2008110355A8 (en) Quinoline derivatives as fungicides
WO2008022286A3 (en) Small molecule inhibitors of kynurenine-3-monooxygenase
WO2009025358A1 (ja) 複素環化合物およびその用途
MX2009011579A (es) Pirimidinonas como moduladores de caseina cinasa ii (ck2).
WO2010027236A3 (en) Fused heterocyclic compound
WO2008140066A3 (en) Pyridone derivatives as p38a mapk inhibitors
TNSN08191A1 (en) Kinase inhibitors
AU2012310674B2 (en) Radioactive fluorine labeled compound
SG196785A1 (en) 3,4,4a,10b-tetrahydro-1h-thiopyrano-[4, 3-c] isoquinoline derivatives
WO2006039250A3 (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
GB201305247D0 (en) Amide Compounds
WO2009097515A3 (en) [a]-fused indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
CY1112554T1 (el) Παραγωγο 4-(3-βενζοϋλαμινοφαινυλ)-6,7-διμεθοξυ-2-μεθυλαμινοκιναζολινης
WO2010019203A8 (en) Antifungal agents
PH12013501147A1 (en) Halogenated biphenols as antibacterial agents